Baird Financial Group’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $259K | Buy |
+11,904
| New | +$230K | ﹤0.01% | 1689 |
|
|
2023
Q2 | – | Sell |
-1,554
| Closed | -$214K | – | 1758 |
|
|
2023
Q1 | $214K | Buy |
1,554
+4
| +0.3% | +$519 | ﹤0.01% | 1600 |
|
|
2022
Q4 | $201K | Sell |
1,550
-1,831
| -54% | -$212K | ﹤0.01% | 1606 |
|
|
2022
Q3 | $374K | Sell |
3,381
-985
| -23% | -$99.3K | ﹤0.01% | 1390 |
|
|
2022
Q2 | $327K | Sell |
4,366
-1,753
| -29% | -$129K | ﹤0.01% | 1512 |
|
|
2022
Q1 | $478K | Sell |
6,119
-1,119
| -15% | -$85.7K | ﹤0.01% | 1424 |
|
|
2021
Q4 | $652K | Sell |
7,238
-183
| -2% | -$15.6K | ﹤0.01% | 1369 |
|
|
2021
Q3 | $686K | Buy |
7,421
+1,640
| +28% | +$126K | ﹤0.01% | 1350 |
|
|
2021
Q2 | $449K | Buy |
5,781
+615
| +12% | +$46.6K | ﹤0.01% | 1434 |
|
|
2021
Q1 | $385K | Buy |
5,166
+806
| +18% | +$74.4K | ﹤0.01% | 1434 |
|
|
2020
Q4 | $743K | Sell |
4,360
-375
| -8% | -$55.6K | ﹤0.01% | 1118 |
|
|
2020
Q3 | $665K | Buy |
4,735
+253
| +6% | +$38.4K | ﹤0.01% | 1072 |
|
|
2020
Q2 | $719K | Sell |
4,482
-613
| -12% | -$83.4K | ﹤0.01% | 1042 |
|
|
2020
Q1 | $498K | Buy |
5,095
+546
| +12% | +$62.4K | ﹤0.01% | 1068 |
|
|
2019
Q4 | $587K | Buy |
4,549
+1,373
| +43% | +$139K | ﹤0.01% | 1125 |
|
|
2019
Q3 | $239K | Buy |
3,176
+1,576
| +99% | +$186K | ﹤0.01% | 1391 |
|
|
2019
Q2 | $244K | Buy |
+1,600
| New | +$194K | ﹤0.01% | 1400 |
|
|
2018
Q2 | – | Sell |
-3,005
| Closed | -$223K | – | 1318 |
|
|
2018
Q1 | $223K | Sell |
3,005
-5,683
| -65% | -$379K | ﹤0.01% | 1191 |
|
|
2017
Q4 | $483K | Sell |
8,688
-1,179
| -12% | -$62.5K | ﹤0.01% | 1025 |
|
|
2017
Q3 | $448K | Buy |
9,867
+998
| +11% | +$39.9K | ﹤0.01% | 1014 |
|
|
2017
Q2 | $299K | Buy |
8,869
+1,319
| +17% | +$42.9K | ﹤0.01% | 1090 |
|
|
2017
Q1 | $223K | Buy |
+7,550
| New | +$234K | ﹤0.01% | 1138 |
|
Other funds holding SRPT
VPM
VCM
RCM
EAM
